Dicerna Pharmaceuticals
Why Robinhood?
You can watch DRNA and buy or sell other stocks, ETFs, and their options commission-free!About DRNA
Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. It uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas.
DRNA Key Statistics
Stock Snapshot
With a market cap of 2.98B, Dicerna Pharmaceuticals(DRNA) trades at $38.22. The stock has a price-to-earnings ratio of -23.44.
On 2026-04-04, Dicerna Pharmaceuticals(DRNA) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Dicerna Pharmaceuticals(DRNA) stock has reached 0, versus its average volume of 3.2M.
Over the past 52 weeks, Dicerna Pharmaceuticals(DRNA) stock has traded between a high of $40.14 and a low of $19.06.
Over the past 52 weeks, Dicerna Pharmaceuticals(DRNA) stock has traded between a high of $40.14 and a low of $19.06.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.